Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. diagnostics commences us clinical
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Magazines
Downloads
Videos

Refine by
Date

  • Older

Diagnostics Commences Us Clinical Articles & Analysis

86 news found

CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research

CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced an expanded portfolio of Polydimethylsiloxane (PDMS) products, empowering researchers with versatile and biocompatible tools for groundbreaking discoveries. Polydimethylsiloxane is an elastomeric polymer with interesting properties for biomedical applications, including ...

ByCD Bioparticles


CD Genomics Revolutionizes Pathogen Discovery with the Launch of Viral Metagenomic Sequencing Service

CD Genomics Revolutionizes Pathogen Discovery with the Launch of Viral Metagenomic Sequencing Service

CD Genomics, a global leader in genomic and bioinformatics solutions, is pleased to announce the official launch of its Viral Metagenomic Sequencing service. This state-of-the-art offering represents a major advancement in the field of pathogen research and promises to provide unparalleled insights into viral communities. Viruses, being the most abundant entities on our planet, play a pivotal ...

ByCD Genomics


CD Genomics Unveils Cutting-edge DAP-Seq Service Revealing the Hidden Secrets of DNA

CD Genomics Unveils Cutting-edge DAP-Seq Service Revealing the Hidden Secrets of DNA

CD Genomics, a global leader in genomics solutions, has recently unveiled its highly anticipated DAP-Seq service. This cutting-edge offering promises to provide researchers worldwide with an efficient application solution for DNA affinity purification sequencing technology. With this service, the company aims to revolutionize the field of life sciences and empower researchers to unlock the ...

ByCD Genomics


CD Genomics Launches Advanced Whole Exome Sequencing Service, Empowering Genetic Research

CD Genomics Launches Advanced Whole Exome Sequencing Service, Empowering Genetic Research

CD Genomics, a renowned provider of genomics services, is proud to unveil its cutting-edge Whole Exome Sequencing (WES) service. This offering provides researchers and clinicians with a powerful tool to investigate the exome, shedding light on the intricacies of the human genome and propelling our understanding of genetic diseases. In the era of precision medicine, comprehensive and precise ...

ByCD Genomics


Vitalograph introduces tremoflo C-100 oscillometer to its extensive range of respiratory diagnostic solutions

Vitalograph introduces tremoflo C-100 oscillometer to its extensive range of respiratory diagnostic solutions

Vitalograph, a global leader in the development and production of respiratory diagnostic solutions and clinical trial services, has launched the Vitalograph tremoflo® C-100 at this year’s ATS International Conference, in Washington. Developed in partnership with Thorasys, the Vitalograph tremoflo® C-100 oscillometer helps to detect the presence of small airway impairment, providing ...

ByVitalograph Inc


Vitalograph introduces tremoflo C-100 oscillometer to its extensive range of respiratory diagnostic solutions

Vitalograph introduces tremoflo C-100 oscillometer to its extensive range of respiratory diagnostic solutions

Vitalograph, a global leader in the development and production of respiratory diagnostic solutions and clinical trial services, has launched the Vitalograph tremoflo® C-100 at this year’s ATS International Conference, taking place in Washington. ...

ByVitalograph Inc


Daxor Corporation Announces Significant Expansion With Five Hospitals Implementing Its BVA-100 Blood Volume Diagnostic for Heart Failure Patients

Daxor Corporation Announces Significant Expansion With Five Hospitals Implementing Its BVA-100 Blood Volume Diagnostic for Heart Failure Patients

Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces five new hospitals have implemented the Company’s BVA-100 blood volume diagnostic for clinical use to guide fluid management in heart failure patients during the first quarter of 2023. The addition of these hospitals contributes to the significant growth of blood volume analysis (BVA) ...

ByDaxor Corporation


Times of San Diego - UCSD Biotech Entrepreneur Wins at UC Innovation Summit

Times of San Diego - UCSD Biotech Entrepreneur Wins at UC Innovation Summit

The University of California recently awarded UC San Diego entrepreneur Jason McKeown for his wearable weight loss technology company Neurovalens, UC announced Monday. McKeown was one of 12 finalists in the third annual UC Entrepreneur Pitch Competition. Six early-stage biotechnology startups and six late-stage biotech businesses were selected to present their pitches at last week’s 2019 ...

ByNeurovalens Limited


Exploring next steps in cancer precision diagnostics using transcriptomics

Exploring next steps in cancer precision diagnostics using transcriptomics

While DNA is largely identical in all cells, RNA fluctuates considerably both in presence and relative concentrations. The variation reflects the underlying cause of a cell’s character and thus RNA analysis gives a more accurate view of the state cells are in compared to DNA analysis. Gene expression levels are important to analyse, and quantitative RNA sequencing is the most informative ...

ByQlucore AB


DNAnexus to Showcase Platform Scalability, Versatility, and Security at ASHG 2022 Annual Meeting

DNAnexus to Showcase Platform Scalability, Versatility, and Security at ASHG 2022 Annual Meeting

DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the speaker lineup for its customer presentations at the American Society of Human Genetics (ASHG) 2022 Annual Meeting, which is being held in Los Angeles this week. The company will also be showcasing its GxP-compliant platform and new Nextflow pipeline language ...

ByDNAnexus, Inc.


Creative Diagnostics Launches Monkeypox Virus Antigens and Antibodies to Accelerate MPXV Study

Creative Diagnostics Launches Monkeypox Virus Antigens and Antibodies to Accelerate MPXV Study

Creative Diagnostics, a global leader in offering raw materials, antibodies, and reagents for the bio-technology industry, announced the launch of Monkeypox Virus Antigens and Antibodies to support scientists focused on the research of monkeypox virus. These products are only intended for research use, not for diagnostic or clinical purposes. Monkeypox is a rare disease caused by infection with ...

ByCreative Diagnostics


VIDA receives 510(k) clearance for deep learning-based enhancements to its LungPrint solution

VIDA receives 510(k) clearance for deep learning-based enhancements to its LungPrint solution

VIDA Diagnostics, Inc. (“VIDA”), the leader in lung and respiratory intelligence, announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for enhancements to its LungPrint solution, including automated deep learning-based lung and lobe segmentation algorithms. This clearance further validates the quality and clinical efficacy of the ...

ByVIDA Diagnostics Inc.


Anavasi Diagnostics Announces New Additions to Leadership Team

Anavasi Diagnostics Announces New Additions to Leadership Team

Anavasi Diagnostics ('Anavasi'), a medical technology company focused on the development of novel molecular diagnostic testing, recently announced the addition of a Chief Financial Officer, Chief Operating Officer and Chief Commercial Officer to its management roster. Scott Hales, Chief Financial Officer of Anavasi Diagnostics, has 30 years of financial, operational and strategic advisory ...

ByAnavasi Diagnostics


CD Genomics RNA-Solutions Platform Now Provides Whole Transcriptome Sequencing Service

CD Genomics RNA-Solutions Platform Now Provides Whole Transcriptome Sequencing Service

RNA-Solutions is a platform for revolutionary research in RNA, targeting coding and non-coding RNAs with different physiological functions. Scientists at CD Genomics are ready to help detect various types of RNAs via meticulous and integrative approaches. Powered by the Illumina, Pacbio SMRT, and Nanopore sequencing platforms, CD Genomics offers services performed by de novo and reference-based ...

ByCD Genomics


Preventative Healthcare Access for All Patients

Preventative Healthcare Access for All Patients

Preventive care is close to my heart. My father died from leukemia when I was 26 years old, and, like many, he only believed in seeing a healthcare provider when he was sick. An annual wellness exam and a simple blood test may have caught his cancer earlier and extended his life. Something so simple, yet many don’t take the time to do. I think about my dad a lot in my career as a ...

ByBabson Diagnostics


WATS3D AI Platform Included in American Gastroenterological Association (AGA) Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett’s Esophagus

WATS3D AI Platform Included in American Gastroenterological Association (AGA) Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett’s Esophagus

CDx Diagnostics, Inc. announced that the WATS3D view, published in Clinical Gastroenterology and Hepatology. WATS3D uses a unique wide-area sampling instrument, proprietary 3D imaging with AI analysis, and expert pathologists to reliably identify abnormal cells to help physicians prevent esophageal cancer. “The CPU is based on a thorough review of the existing clinical literature and ...

ByCDx Diagnostics Inc.


SEngine Precision Medicine closes Series A bringing total financing to $19M enabling continued advancement of personalized cancer treatments

SEngine Precision Medicine closes Series A bringing total financing to $19M enabling continued advancement of personalized cancer treatments

SEATTLE, July 28, 2022 (GLOBE NEWSWIRE) -- Seattle-based Precision Oncology company SEngine Precision Medicine has now raised a total of $19M, following the recent closing of a $10M Series A2, as it continues to commercialize a platform that matches cancer patients to the right drug and also drives drug discovery. The Series A2 round was led by the Washington Research Foundation along with ...

BySEngine Precision Medicine


MOBILion Systems Appoints Jenn Buechel to its Board of Directors

MOBILion Systems Appoints Jenn Buechel to its Board of Directors

MOBILion System Inc. (Chadds Ford, PA), a life science tools and instrumentation company commercializing a best-in-class technology to separate, identify, and analyze the most challenging molecules other instruments fail to detect, announced that it has appointed Jenn Buechel to serve on its Board of Directors, effective immediately. Ms. Buechel, currently the Chief Operating Officer of Delfi ...

ByMOBILion Systems, Inc.


Creative Diagnostics Launches Monkeypox Virus Antibodies and Antigens to Support MPXV Research

Creative Diagnostics Launches Monkeypox Virus Antibodies and Antigens to Support MPXV Research

Creative Diagnostics, a global leader in offering raw materials, antibodies, and reagents for the bio-technology industry, announced the launch of several Monkeypox Virus Antibodies and Antigens that have been validated to work in various types of immunoassays and can be used as tools for the detection of Monkeypox viruses. Monkeypox virus (MPV or MPXV) is a double-stranded DNA virus that causes ...

ByCreative Diagnostics


STEMart Introduces New Antibiotic Potency Tests for Medical Devices

STEMart Introduces New Antibiotic Potency Tests for Medical Devices

STEMart, a provider of CRO services dedicated to integrated medical device and diagnostic clinical development, introduced new Antibiotic Potency Tests to assess the bioactivity or potency of various antibiotics for medical devices. The development of these new tests strictly follows the Antibiotics-Microbial Assays in USP General Chapter 81 to ensure the highest efficacy. Microbial potency ...

BySTEMart

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT